0.860
0.01 (0.87%)
| Penutupan Terdahulu | 0.853 |
| Buka | 0.860 |
| Jumlah Dagangan | 86,423 |
| Purata Dagangan (3B) | 116,745 |
| Modal Pasaran | 40,281,508 |
| Harga / Pendapatan (P/E Ke hadapan) | 11.70 |
| Harga / Jualan (P/S) | 5.37 |
| Harga / Buku (P/B) | 0.860 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 17 Aug 2026 |
| Margin Operasi (TTM) | -749.51% |
| EPS Cair (TTM) | -0.770 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 1.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 8.19% |
| Nisbah Semasa (MRQ) | 4.36 |
| Aliran Tunai Operasi (OCF TTM) | -25.60 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -13.62 M |
| Pulangan Atas Aset (ROA TTM) | -58.16% |
| Pulangan Atas Ekuiti (ROE TTM) | -113.95% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | InspireMD Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.33 |
|
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 30.14% |
| % Dimiliki oleh Institusi | 42.29% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Affiance Financial, Llc | 30 Jun 2026 | 250,370 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |